<DOC>
	<DOCNO>NCT01027494</DOCNO>
	<brief_summary>The purpose observational study evaluate effect topical fluoroquinolone ( antibiotic ) instill otic ( ear ) canal treat Acute Otitis Media Tympanostomy Tubes ( AOMT ) select bacterial specie skin near ear , nose , throat .</brief_summary>
	<brief_title>Topical Treatment Acute Otitis Media Through Tympanostomy Tubes ( AOMT ) Its Effect Microbial Flora</brief_title>
	<detailed_description>Pediatric patient tympanostomy tube enrol one two group : 1 ) Treatment , i.e. , patient sign otic infection , treat CIPRODEX ; 2 ) Healthy , i.e. , patient without sign otic infection , receive treatment . Microbiological specimen collect four area ( ear canal , skin , nose , throat ) three study visit ( Day 1 , Day 8 , Day 42 ) , specimens collect Healthy group serve comparison ( control ) group identify fluoroquinolone ( FQ ) resistant bacterial strain .</detailed_description>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Six month le 5 year age time enrollment ; Presence bilateral , patent tympanostomy tube ; Otorrheafree least 7 day follow tympanostomy tube surgery ( healthy group ) ; Otorrhea include 21 day duration least one ear Visit 1 ( treatment group ) ; Willing refrain significant water immersion ear without use adequate ear protection swimming , bathing , shower waterrelated activity ; Read sign inform consent ( parent guardian ) ; Other protocoldefined inclusion criterion may apply . Ongoing/current therapy describe protocol ; Has receive treatment current AOMT episode ( treatment group ) ; Otorrhea great 21 day duration immediately prior Day 1 visit ( treatment group ) ; History current acute chronic nontube otorrhea ( exist perforation eardrum ) ; Current acute otitis externa ( AOE ) , malignant otitis externa ( MOE ) condition could interfere evaluation study drug ; Known suspect ear infection fungal mycobacterial origin ( treatment group ) ; History active herpes simplex , vaccina varicella infection overt viral infection tympanic membrane external canal ; Prior otologic surgery , except confine tympanic membrane , within one year study entry ; Diabetes ; Any current know suspected infection ( AOMT ) require systemic antimicrobial therapy ; Known suspect allergy hypersensitivity quinolones ; Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>4 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>ear tube</keyword>
	<keyword>ear drainage</keyword>
	<keyword>ear infection</keyword>
	<keyword>ear drop</keyword>
	<keyword>tympanostomy tube</keyword>
</DOC>